Max Planck Institute for Human Development
11
0
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Ovarian Cancer Screening and AI
Role: collaborator
Cognitive Function Evaluation and Rehabilitation by a Digital Game: MentalPlus®
Role: collaborator
Digital Game: A Scale to Evaluate the Perioperative Cognitive Function
Role: collaborator
A Global Approach to Tackle Cognitive Decline
Role: collaborator
Brain Changes in Response to Long-Duration Isolation and Confinement
Role: collaborator
Evaluation of an Interactive Risk Information Tool to Increase COVID-19 Vaccination Incidence in Vaccine-hesitant People
Role: collaborator
Family Meal Duration and Children's Eating Behavior
Role: lead
Are Offline Meals Healthy Meals? A Field Experiment to Promote Healthier Eating in Families
Role: collaborator
Improving Discharge Communication in the Emergency Department Through Information Structuring
Role: collaborator
Resuscitation Decisions in the Emergency Department (ED)
Role: collaborator
Doctors' Understanding of Survival Statistics
Role: lead
All 11 trials loaded